Skip to main content


Metastate Welcomes Benjamin Gerber as Chief Technology Officer

We are excited to announce that Benjamin Gerber has joined Metastate as our new Chief Technology Officer (CTO). This addition significantly bolsters our capabilities in advancing synthetic biology and metabolomics research.

Metastate's First Presentation at MANA 2023

We're pleased to report that Metastate successfully presented at the Metabolomics Association North America (MANA) 2023 Conference. The event provided us with an excellent platform to introduce our specialized software to professionals in the field of synthetic biology and metabolomics research.

Metastate Beta is Open for Everyone

We're excited to announce that MetaState has officially launched its Open Beta phase. This pivotal moment opens doors for researchers to experience the cutting-edge capabilities of our platform firsthand. MetaState is poised to revolutionize metabolomics and synthetic biology research, providing a comprehensive suite of tools for designing genetic circuits, metabolic pathways, and cell models. Join us in shaping the future of science and biotechnology. Explore MetaState in Open Beta now and witness the transformation of research possibilities. 

Join the Conversation: Metastate's Optional Slack Channel

We are dedicated to fostering collaboration and knowledge sharing among researchers in the field of metabolomics and synthetic biology. To facilitate seamless communication, we are excited to introduce an optional Slack channel for Metastate users. By joining the Metastate Slack community, you can connect with fellow researchers, exchange ideas, and stay updated on the latest developments. Don't miss out on the opportunity to engage with a community of like-minded professionals and enhance your research journey with Metastate.

Metastate Takes a Leap: Open Beta on the Horizon

We are excited to share a momentous development with our community. Metastate, the revolutionary metabolomics software, is gearing up for its next major phase: the Open Beta. Following the successful completion of our Closed Beta, we are preparing to offer broader access to Metastate's innovative platform. Researchers, scientists, and professionals in the field of synthetic biology will soon have the opportunity to explore and harness the full potential of Metastate's comprehensive metabolomics analysis tools.

Whitepaper: Empowering Metabolomics Research and Development: Unveiling the Potential of MetaState

Metabolomics, the study of small molecules and their interactions within an organism, plays a crucial role in unlocking the mysteries of biological processes. At MetaState, we are dedicated to propelling metabolomics research and development to new heights. We are thrilled to introduce our latest article, "Empowering Metabolomics Research and Development: Unveiling the Potential of MetaState," which takes you on a journey through the intricate world of metabolomics and showcases how our platform is revolutionizing this field.

Exciting News: Metastate Enters Closed Beta Phase!

We are thrilled to announce a significant milestone in our journey. Metastate, the cutting-edge metabolomics software, has officially entered its Closed Beta phase. Since May, a select group of researchers and professionals have had the exclusive opportunity to experience the power and capabilities of Metastate's metabolomics analysis tools. This closed beta period marks a crucial step towards refining and perfecting our platform before its anticipated launch. 

MetaState: A software platform for synthetic biology and metabolomics MetaState is a software platform that enables researchers to create, simulate, and optimize synthetic biology projects.